A significant discovery in cancer research is arising with the use of VHH fragments to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in several types of cancer, resulting https://socialtechnet.com/story7548878/nanobodies-revive-the-p53-protein-the-new-hope-for-malignant-management